Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Inv. presentation
|
|
BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/20/2021 |
GN
| BioDelivery Sciences to Report First Quarter 2021 Financial Results on May 6, 2021 |
| 03/10/2021 |
GN
| BioDelivery Sciences Reports Strong Q4 and Record Full-Year 2020 Results |
| 02/17/2021 |
GN
| BioDelivery Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021 |
| 11/20/2020 |
GN
| BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference |
| 11/11/2020 |
GN
| BioDelivery Sciences to Present Virtually and Host 1x1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18 |
| 11/05/2020 |
GN
| BioDelivery Sciences Reports Strong Q3 2020 Results |
| 11/04/2020 |
GN
| BioDelivery Sciences Announces $25 Million Share Repurchase Program |
| 11/04/2020 |
GN
| BioDelivery Sciences Announces Appointment of Jeff Bailey as Permanent CEO |
| 10/23/2020 |
GN
| BioDelivery Sciences to Report Third Quarter 2020 Financial Results on November 5, 2020 |
| 09/11/2020 |
GN
| BioDelivery Sciences Announces Five Scientific Poster Presentations at PAINWeek® 2020 National Conference on Pain Management |
| 08/05/2020 |
GN
| BioDelivery Sciences Reports Strong Q2 2020 Results |
| 05/29/2020 |
GN
| BioDelivery Sciences to Present at Two Upcoming Investor Conferences |
| 05/11/2020 |
GN
| BioDelivery Sciences Appoints Jeff Bailey Interim CEO |
| 04/28/2020 |
GN
| BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020 |
| 02/27/2020 |
GN
| BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicine's 36th Annual Meeting |
| 01/06/2020 |
GN
| BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business Development |
| 12/19/2019 |
GN
| BioDelivery Sciences Added to NASDAQ Biotechnology Index |
| 11/27/2019 |
GN
| BioDelivery Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference |
| 11/25/2019 |
GN
| BioDelivery Sciences Appoints Dr. Vanila Singh, Former Chief Medical Officer of Health and Human Services, to its Board of Directors |
| 11/12/2019 |
GN
| BioDelivery Sciences Reports Strong Third Quarter Results, Raises Full Year 2019 and Provides 2020 Net Sales Expectations |
| 10/01/2019 |
GN
| BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCA® and Symproic® |
| 09/17/2019 |
GN
| BioDelivery Sciences Announces Participation in Upcoming Investor Conferences |
| 08/29/2019 |
GN
| BioDelivery Sciences Announces Upcoming Investor Conference Presentations |
| 08/28/2019 |
GN
| BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management |
| 07/30/2019 |
GN
| BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019 |
| 06/24/2019 |
GN
| BioDelivery Sciences Expands Upon Report from Pain Management Task Force |
| 06/20/2019 |
GN
| BioDelivery Sciences Named to the Russell 3000® Index |
| 05/29/2019 |
GN
| BioDelivery Sciences Announces Upcoming Investor Conference Presentations |
| 05/28/2019 |
GN
| BioDelivery Sciences Strengthens Financial Position with Debt Refinancing |
| 04/11/2019 |
GN
| BioDelivery Sciences International, Inc. Announces Pricing of Public Offering of Common Stock |
| 04/10/2019 |
GN
| BioDelivery Sciences International, Inc. Announces Proposed Underwritten Public Offering of Common Stock |
| 04/10/2019 |
GN
| BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic® |
| 02/19/2019 |
GN
| Factors of Influence in 2019, Key Indicators and Opportunity within Procter & Gamble, Hertz Global, NN, Omnicell, BioDelivery Sciences International, and Movado Group — New Research Emphasizes Economic Growth |
| 02/04/2019 |
GN
| BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA® |
|
|
|